Biotech MetaVia Announces Completion of Last Patient Visit in Extended 24-Week Phase 1 Part 3A Study of DA-1726 November 18, 2026
Biotech RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor “What This Means” Segment November 17, 2026
Biotech Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma November 17, 2026
Biotech Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company November 17, 2026
Biotech Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026 November 17, 2026
Biotech Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development November 17, 2026
Biotech ProMIS Neurosciences Licenses Next-Generation TXP1 Brain-Selective Shuttling Technology from Ossianix to Expand PMN310 Franchise and Pipeline November 17, 2026
Biotech Palatin Technologies Presents Compelling Preclinical Data on Next-Generation MC4R-Selective Peptide Agonists at ObesityWeek® 2026 November 17, 2026
Biotech Nuvation Bio Presented Additional Long-Term Follow-Up Data from Phase 2 Study of Safusidenib in IDH1-Mutant Glioma at the 2026 Society for Neuro-Oncology Annual Meeting November 17, 2026